• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 疫苗:当前进展状况。

Vaccines for COVID-19: The current state of play.

机构信息

National Centre for Immunisation Research and Surveillance, Westmead, NSW, Australia; Department of Infectious Diseases, Nepean Hospital, Penrith, NSW, Australia.

National Centre for Immunisation Research and Surveillance, Westmead, NSW, Australia.

出版信息

Paediatr Respir Rev. 2020 Sep;35:43-49. doi: 10.1016/j.prrv.2020.06.010. Epub 2020 Jun 18.

DOI:10.1016/j.prrv.2020.06.010
PMID:32653463
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7301825/
Abstract

There is a strong consensus globally that a COVID-19 vaccine is likely the most effective approach to sustainably controlling the COVID-19 pandemic. An unprecedented research effort and global coordination has resulted in a rapid development of vaccine candidates and initiation of trials. Here, we review vaccine types, and progress with 10 vaccine candidates against SARS-CoV-2 - the virus that causes COVID-19 - currently undergoing early phase human trials. We also consider the many challenges of developing and deploying a new vaccine on a global scale, and recommend caution with respect to our expectations of the timeline that may be ahead.

摘要

全球范围内有一个强烈的共识,即 COVID-19 疫苗可能是可持续控制 COVID-19 大流行的最有效方法。前所未有的研究努力和全球协调导致了疫苗候选物的快速开发和试验启动。在这里,我们回顾了针对导致 COVID-19 的 SARS-CoV-2 病毒的 10 种疫苗候选物的类型和进展,这些候选物目前正在进行早期人体试验。我们还考虑了在全球范围内开发和部署新疫苗所面临的许多挑战,并对我们对未来可能出现的时间表的期望持谨慎态度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75e3/7301825/eb32732d23e0/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75e3/7301825/eb32732d23e0/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75e3/7301825/eb32732d23e0/gr1_lrg.jpg

相似文献

1
Vaccines for COVID-19: The current state of play.COVID-19 疫苗:当前进展状况。
Paediatr Respir Rev. 2020 Sep;35:43-49. doi: 10.1016/j.prrv.2020.06.010. Epub 2020 Jun 18.
2
Vaccine Candidates against Coronavirus Infections. Where Does COVID-19 Stand?针对冠状病毒感染的疫苗候选者。COVID-19 处于什么位置?
Viruses. 2020 Aug 7;12(8):861. doi: 10.3390/v12080861.
3
A systematic review of SARS-CoV-2 vaccine candidates.SARS-CoV-2 疫苗候选物的系统评价。
Signal Transduct Target Ther. 2020 Oct 13;5(1):237. doi: 10.1038/s41392-020-00352-y.
4
Progress and Challenges in the Development of COVID-19 Vaccines and Current Understanding of SARS-CoV-2- Specific Immune Responses.COVID-19 疫苗研发的进展与挑战及对 SARS-CoV-2 特异性免疫应答的现有认识。
J Microbiol Biotechnol. 2020 Aug 28;30(8):1109-1115. doi: 10.4014/jmb.2006.06006.
5
SARS-CoV-2: A New Song Recalls an Old Melody.SARS-CoV-2:一首新歌唤起旧旋律。
Cell Host Microbe. 2020 May 13;27(5):692-694. doi: 10.1016/j.chom.2020.04.019.
6
Potential adjuvants for the development of a SARS-CoV-2 vaccine based on experimental results from similar coronaviruses.基于类似冠状病毒的实验结果开发 SARS-CoV-2 疫苗的潜在佐剂。
Int Immunopharmacol. 2020 Sep;86:106717. doi: 10.1016/j.intimp.2020.106717. Epub 2020 Jun 18.
7
[Strategies for vaccine development of COVID-19].[新型冠状病毒肺炎疫苗研发策略]
Sheng Wu Gong Cheng Xue Bao. 2020 Apr 25;36(4):593-604. doi: 10.13345/j.cjb.200094.
8
SARS-CoV-2: previous coronaviruses, immune response, and development of vaccines.严重急性呼吸综合征冠状病毒2:既往冠状病毒、免疫反应及疫苗研发
Bol Med Hosp Infant Mex. 2020;77(5):252-261. doi: 10.24875/BMHIM.20000191.
9
Developing a low-cost and accessible COVID-19 vaccine for global health.为全球健康研发一种低成本且易于获取的新冠疫苗。
PLoS Negl Trop Dis. 2020 Jul 29;14(7):e0008548. doi: 10.1371/journal.pntd.0008548. eCollection 2020 Jul.
10
The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.迈向 COVID-19 群体免疫的漫长道路:疫苗平台技术和大规模免疫策略。
Front Immunol. 2020 Jul 21;11:1817. doi: 10.3389/fimmu.2020.01817. eCollection 2020.

引用本文的文献

1
Nucleic acid vaccines: innovations, efficacy, and applications in at-risk populations.核酸疫苗:创新、疗效及在高危人群中的应用
Front Immunol. 2025 May 14;16:1584876. doi: 10.3389/fimmu.2025.1584876. eCollection 2025.
2
Effect of SpikoGen subunit vaccine administration during pregnancy on fetal development of rats.孕期接种SpikoGen亚单位疫苗对大鼠胎儿发育的影响。
Clin Exp Vaccine Res. 2024 Oct;13(4):301-308. doi: 10.7774/cevr.2024.13.4.301. Epub 2024 Oct 31.
3
Comparative assessment of a COVID-19 vaccine after technology transfer to Iran from critical quality attributes to clinical and immunogenicity aspects.

本文引用的文献

1
COVID-19 vaccine development pipeline gears up.新冠疫苗研发进程加速推进。
Lancet. 2020 Jun 6;395(10239):1751-1752. doi: 10.1016/S0140-6736(20)31252-6.
2
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial.一种基于重组腺病毒 5 型的 COVID-19 疫苗的安全性、耐受性和免疫原性:一项剂量递增、开放标签、非随机、首次人体试验。
Lancet. 2020 Jun 13;395(10240):1845-1854. doi: 10.1016/S0140-6736(20)31208-3. Epub 2020 May 22.
3
Herd Immunity: Understanding COVID-19.
将 COVID-19 疫苗技术从关键质量属性转移到伊朗后的临床和免疫原性方面的比较评估。
Sci Rep. 2024 Nov 5;14(1):26793. doi: 10.1038/s41598-024-77331-8.
4
Mathematical Modeling of SARS-CoV-2 Omicron Wave under Vaccination Effects.接种疫苗影响下的新冠病毒奥密克戎毒株浪潮的数学建模
Computation (Basel). 2023 Feb;11(2). doi: 10.3390/computation11020036. Epub 2023 Feb 15.
5
Recent SARS-CoV-2 Outlook and Implications in a COVID-19 Vaccination Era.新冠疫苗接种时代的新型冠状病毒2019近期展望及影响
Infect Microbes Dis. 2021 Aug 13;3(3):125-133. doi: 10.1097/IM9.0000000000000072. eCollection 2021 Sep.
6
Africa's preparedness towards COVID-19 vaccines: Demand and acceptability challenges.非洲对新冠疫苗的准备情况:需求和可接受性挑战
Curr Res Behav Sci. 2021 Nov;2:100048. doi: 10.1016/j.crbeha.2021.100048. Epub 2021 May 24.
7
Enhancing explainable SARS-CoV-2 vaccine development leveraging bee colony optimised Bi-LSTM, Bi-GRU models and bioinformatic analysis.利用蜜蜂群体优化的 Bi-LSTM、Bi-GRU 模型和生物信息学分析增强 SARS-CoV-2 疫苗的可解释性开发。
Sci Rep. 2024 Mar 20;14(1):6737. doi: 10.1038/s41598-024-55762-7.
8
Association of Cardiovascular Events with COVID-19 Vaccines Using Vaccine Adverse Event Reporting System (VAERS): A Retrospective Study.使用疫苗不良事件报告系统 (VAERS) 评估心血管事件与 COVID-19 疫苗的相关性:一项回顾性研究。
Curr Drug Saf. 2024;19(3):402-406. doi: 10.2174/0115748863276904231108095255.
9
Circular RNA vaccine in disease prevention and treatment.环状 RNA 疫苗在疾病防治中的应用。
Signal Transduct Target Ther. 2023 Sep 11;8(1):341. doi: 10.1038/s41392-023-01561-x.
10
Exploring public sentiment and vaccination uptake of COVID-19 vaccines in England: a spatiotemporal and sociodemographic analysis of Twitter data.探究英格兰民众对 COVID-19 疫苗的情绪和接种情况:基于 Twitter 数据的时空和社会人口学分析。
Front Public Health. 2023 Aug 17;11:1193750. doi: 10.3389/fpubh.2023.1193750. eCollection 2023.
群体免疫:了解 COVID-19。
Immunity. 2020 May 19;52(5):737-741. doi: 10.1016/j.immuni.2020.04.012.
4
Serological Approaches for COVID-19: Epidemiologic Perspective on Surveillance and Control.血清学方法在新冠病毒中的应用:监测与控制的流行病学视角。
Front Immunol. 2020 Apr 24;11:879. doi: 10.3389/fimmu.2020.00879. eCollection 2020.
5
Considering BCG vaccination to reduce the impact of COVID-19.考虑接种卡介苗以减轻新型冠状病毒肺炎的影响。
Lancet. 2020 May 16;395(10236):1545-1546. doi: 10.1016/S0140-6736(20)31025-4. Epub 2020 Apr 30.
6
Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial.一种中东呼吸综合征冠状病毒病毒载体候选疫苗的安全性和免疫原性:剂量递增、开放性、非随机、非对照、1 期临床试验。
Lancet Infect Dis. 2020 Jul;20(7):816-826. doi: 10.1016/S1473-3099(20)30160-2. Epub 2020 Apr 21.
7
Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial.一种用于中东呼吸综合征的改良安卡拉痘苗病毒载体候选疫苗的安全性和免疫原性:一项开放性、1 期临床试验。
Lancet Infect Dis. 2020 Jul;20(7):827-838. doi: 10.1016/S1473-3099(20)30248-6. Epub 2020 Apr 21.
8
Coronavirus Infections in Children Including COVID-19: An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children.儿童冠状病毒感染包括 COVID-19:儿童流行病学、临床特征、诊断、治疗和预防选择概述。
Pediatr Infect Dis J. 2020 May;39(5):355-368. doi: 10.1097/INF.0000000000002660.
9
Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment.新型 2019 年冠状病毒结构、作用机制、抗病毒药物前景及其治疗排除。
J Biomol Struct Dyn. 2021 Jun;39(9):3409-3418. doi: 10.1080/07391102.2020.1758788. Epub 2020 Apr 30.
10
Initial impacts of global risk mitigation measures taken during the combatting of the COVID-19 pandemic.在抗击新冠疫情期间采取的全球风险缓解措施的初步影响。
Saf Sci. 2020 Aug;128:104773. doi: 10.1016/j.ssci.2020.104773. Epub 2020 Apr 15.